BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30350198)

  • 1. Detection and Functional Analysis of TP53 Mutations in CLL.
    Pavlova S; Smardova J; Tom N; Trbusek M
    Methods Mol Biol; 2019; 1881():63-81. PubMed ID: 30350198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.
    De Luca G; Cerruti G; Lastraioli S; Conte R; Ibatici A; Di Felice N; Morabito F; Monti P; Fronza G; Matis S; Colombo M; Fabris S; Ciarrocchi A; Neri A; Menichini P; Ferrarini M; Nozza P; Fais F; Cutrona G; Dono M
    Hematol Oncol; 2022 Dec; 40(5):962-975. PubMed ID: 35961859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods.
    Kantorova B; Malcikova J; Smardova J; Pavlova S; Trbusek M; Tom N; Plevova K; Tichy B; Truong S; Diviskova E; Kotaskova J; Oltova A; Patten N; Brychtova Y; Doubek M; Mayer J; Pospisilova S
    Tumour Biol; 2015 May; 36(5):3371-80. PubMed ID: 25527155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.
    Minervini CF; Cumbo C; Orsini P; Brunetti C; Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Impera L; Giordano A; Specchia G; Albano F
    Diagn Pathol; 2016 Oct; 11(1):96. PubMed ID: 27724982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.
    Pekova S; Mazal O; Cmejla R; Hardekopf DW; Plachy R; Zejskova L; Haugvicova R; Jancuskova T; Karas M; Koza V; Smolej L; Bezdickova L; Kozak T
    Leuk Res; 2011 Jul; 35(7):889-98. PubMed ID: 21232794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
    Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
    J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.
    Malcikova J; Pavlova S; Kozubik KS; Pospisilova S
    Hum Mutat; 2014 Jun; 35(6):663-71. PubMed ID: 24415659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukaemia cases using multiple polymerases.
    Worrillow L; Baskaran P; Care MA; Varghese A; Munir T; Evans PA; O'Connor SJ; Rawstron A; Hazelwood L; Tooze RM; Hillmen P; Newton DJ
    Oncogene; 2016 Oct; 35(40):5328-5336. PubMed ID: 27041575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia.
    Malcikova J; Stano-Kozubik K; Tichy B; Kantorova B; Pavlova S; Tom N; Radova L; Smardova J; Pardy F; Doubek M; Brychtova Y; Mraz M; Plevova K; Diviskova E; Oltova A; Mayer J; Pospisilova S; Trbusek M
    Leukemia; 2015 Apr; 29(4):877-85. PubMed ID: 25287991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of TP53 for CLL diagnostics.
    Catherwood MA; Gonzalez D; Donaldson D; Clifford R; Mills K; Thornton P
    J Clin Pathol; 2019 May; 72(5):343-346. PubMed ID: 30712002
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-level TP53 mutational load antecedes clonal expansion in chronic lymphocytic leukaemia.
    Pinto AM; Papa FT; Frullanti E; Meloni I; Tita R; Caselli R; Fallerini C; Lopergolo D; Cetta F; Mencarelli MA; Bocchia M; Gozzetti A; Renieri A
    Br J Haematol; 2019 Feb; 184(4):657-659. PubMed ID: 29460960
    [No Abstract]   [Full Text] [Related]  

  • 12. Deep targeted sequencing of
    Brieghel C; Kinalis S; Yde CW; Schmidt AY; Jønson L; Andersen MA; da Cunha-Bang C; Pedersen LB; Geisler CH; Nielsen FC; Niemann CU
    Haematologica; 2019 Apr; 104(4):789-796. PubMed ID: 30514802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia.
    Quijada-Álamo M; Hernández-Sánchez M; Robledo C; Hernández-Sánchez JM; Benito R; Montaño A; Rodríguez-Vicente AE; Quwaider D; Martín AÁ; García-Álvarez M; Vidal-Manceñido MJ; Ferrer-Garrido G; Delgado-Beltrán MP; Galende J; Rodríguez JN; Martín-Núñez G; Alonso JM; García de Coca A; Queizán JA; Sierra M; Aguilar C; Kohlmann A; Hernández JÁ; González M; Hernández-Rivas JM
    J Hematol Oncol; 2017 Apr; 10(1):83. PubMed ID: 28399885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes.
    Lazarian G; Tausch E; Eclache V; Sebaa A; Bianchi V; Letestu R; Collon JF; Lefebvre V; Gardano L; Varin-Blank N; Soussi T; Stilgenbauer S; Cymbalista F; Baran-Marszak F
    Int J Cancer; 2016 Oct; 139(8):1759-63. PubMed ID: 27270786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
    Vollbrecht C; Mairinger FD; Koitzsch U; Peifer M; Koenig K; Heukamp LC; Crispatzu G; Wilden L; Kreuzer KA; Hallek M; Odenthal M; Herling CD; Buettner R
    PLoS One; 2015; 10(6):e0129544. PubMed ID: 26053404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
    Sutton LA; Ljungström V; Mansouri L; Young E; Cortese D; Navrkalova V; Malcikova J; Muggen AF; Trbusek M; Panagiotidis P; Davi F; Belessi C; Langerak AW; Ghia P; Pospisilova S; Stamatopoulos K; Rosenquist R
    Haematologica; 2015 Mar; 100(3):370-6. PubMed ID: 25480502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia.
    Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martіna ZV
    Exp Oncol; 2014 Dec; 36(4):258-61. PubMed ID: 25537220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
    Malcikova J; Tausch E; Rossi D; Sutton LA; Soussi T; Zenz T; Kater AP; Niemann CU; Gonzalez D; Davi F; Gonzalez Diaz M; Moreno C; Gaidano G; Stamatopoulos K; Rosenquist R; Stilgenbauer S; Ghia P; Pospisilova S;
    Leukemia; 2018 May; 32(5):1070-1080. PubMed ID: 29467486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients.
    Kantorova B; Malcikova J; Brazdilova K; Borsky M; Plevova K; Smardova J; Radova L; Tom N; Trbusek M; Diviskova E; Francova HS; Navrkalova V; Doubek M; Brychtova Y; Mayer J; Pospisilova S
    Br J Haematol; 2017 Sep; 178(6):979-982. PubMed ID: 27470445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.